476
Participants
Start Date
October 1, 2022
Primary Completion Date
March 1, 2023
Study Completion Date
March 1, 2023
Clopidogrel
Treatment with dual antiplatelet drug,aspirin 80 mg PO daily with clopidogrel 75 mg PO daily
Ticagrelor
Treatment with dual antiplatelet drug,aspirin 80 mg PO daily with ticagrelor 90 mg PO twice daily
Professor Kojuri Cardiology Clinic, Shiraz
Shiraz University of Medical Sciences
OTHER